Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $23.8900 (-0.17%) ($23.6400 - $24.3600) on Tue. Jun. 9, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.07% (three month average) | RSI | 55 | Latest Price | $23.8900(-0.17%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -0.3% a day on average for past five trading days. | Weekly Trend | HALO declines -1.1% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IWO(51%) IBB(50%) IWM(47%) IWC(44%) ARKG(43%) | Factors Impacting HALO price | HALO will decline at least -2.035% in a week (0% probabilities). VIXM(-31%) UUP(-15%) VXX(-14%) TLT(-3%) IGOV(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.035% (StdDev 4.07%) | Hourly BBV | 0 () | Intraday Trend | -0.1% | | | |
|
Resistance Level | $23.95 | 5 Day Moving Average | $23.66(0.97%) | 10 Day Moving Average | $23.84(0.21%) | 20 Day Moving Average | $23.95(-0.25%) | To recent high | -3.7% | To recent low | 71.9% | Market Cap | $3.265b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |